Search Results 811-820 of 18503 for Prednisone

1. A Study to Explore the Safety and Tolerability of Acthar in Patients With Amyotrophic Lateral Sclerosis - Mayo Clinic

   Chronic systemic corticosteroid use, defined as > 20 mg of prednisone or equivalent systemic corticosteroid taken for more than 4 consecutive weeks within 6 ...

2. Hemin (intravenous route) - Mayo Clinic

   Lumacaftor; Mitotane; Modafinil; Nafcillin; Nevirapine; Oxcarbazepine; Phenobarbital; Phenytoin; Prednisone; Primidone; Rifabutin; Rifampin; Ritonavir; St ...

3. RP2/RP3 in Combination With Atezolizumab and Bevacizumab for the Treatment of Patients With CRC - Mayo Clinic

   only if the dose does not exceed 10 mg/day prednisone equivalent. 21. Conditions in which anticoagulant therapies cannot be safely stopped in the

4. A Study Of The Gala Airway Treatment System For The Treatment Of Chronic Bronchitis In The United States - Mayo Clinic

   Subject is taking > 10 mg of prednisolone or prednisone per day. Subject has an implantable cardioverter defibrillator or pacemaker. Subject has a history ...

5. A Study of Enfortumab Vedotin for Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer - Mayo Clinic

   If requiring steroid treatment for CNS metastases, the patient is on a stable dose ≤20 mg/day of prednisone or equivalent for at least 2 weeks;; Patient ...

6. Tacrolimus (topical route) - Mayo Clinic

   Atopic dermatitis is a skin condition where there is itching, redness, and inflammation, much like an allergic reaction. Tacrolimus helps to suppress these ...

7. A Study of Atezolizumab (Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) in Combination With Carboplatin Plus (+) Nab-Paclitaxel Compared With Carboplatin + Nab-Paclitaxel in Participants With Non-Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower130) - Mayo Clinic

   ... prednisone or equivalent), systemic immunosuppressant medications may be enrolled in the study. The use of corticosteroids (≤ 10 mg oral prednisone or ...

8. Belimumab in Remission of VASculitis - Clinical Trials

   Remission is defined as a Birmingham Vasculitis Activity (BVAS) score of 0 and receiving less than 10 mg/day of oral prednisone (or equivalent) on 2 consecutive ...

9. A Study to Estimate the Clinical Benefit of REGN2810 for Patients with Advanced Squamous Cell Skin Cancer

   Immunosuppressive corticosteroid doses (>10 mg prednisone daily or equivalent) within 4 weeks prior to the first dose of REGN2810; Infection with human ...

10. An Open-Label Extension of RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis - Mayo Clinic

    Treatment with corticosteroids at a dose that exceeds the prednisone equivalent of 40 mg per day;; Treatment with immunosuppressive agents (e.g. ...